Insights

Gathering insights about ICP…

Similar companies to ICP

ICP Tech Stack

ICP uses 8 technology products and services including RSS, Cookie Notice, React, and more. Explore ICP's tech stack below.

RSS
Content Management System
Cookie Notice
Cookie Compliance
React
Javascript Frameworks
Slick
Javascript Libraries
WP Engine
Platform As A Service
a3 Lazy Load
Web Platform Extensions
Facebook
Widgets
Google Plus
Widgets

Media & News

Intercept Pharma withdraws liver disease drug from US market
Intercept Pharmaceuticals said on Thursday it is voluntarily withdrawing its liver disease treatment from the U.S. market following a request from the Food and Drug Administration.
Sep 11, 2025 | www.reuters.com
US FDA says Intercept's drug can cause liver injury in patients without scarring
Intercept Pharmaceuticals' liver disease drug can cause injury to the organ in patients without severe scarring, the U.S. Food and Drug Administration said on Thursday, based on its review of postmarket clinical trial data.
Dec 12, 2024 | www.reuters.com
US FDA declines full approval for Intercept's liver disease drug
The U.S. Food and Drug Administration on Tuesday declined full approval for Intercept Pharmaceuticals' liver disease drug, raising questions about its future in the market.
Nov 12, 2024 | www.reuters.com
Intercept Receives Complete Response Letter from FDA Addressing OCALIVA supplemental New Drug Application (sNDA)
MORRISTOWN, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc., a wholly owned biopharmaceutical subsidiary of Alfasigma S.p.A., today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) that addresses the supplemental New Drug Application (sNDA) for OCALIVA® (obeticholic acid, OCA) seeking full approval for the treatment of indicated patients with primary biliary cholangitis (PBC) – a rare, progressive disease that disproportionally affects women.
Nov 12, 2024 | www.globenewswire.com
FDA advisers vote against confirmatory data for Intercept's liver disease drug
Independent advisers to the U.S. Food and Drug Administration voted on Friday against confirmatory trial data for Intercept Pharmaceuticals' liver disease drug, putting into question the treatment's future in the U.S. market.
Sep 13, 2024 | www.reuters.com
FDA staff raises efficacy concerns over Intercept's liver disease drug
The U.S. Food and Drug Administration's staff on Wednesday raised concerns over the efficacy of Intercept Pharmaceuticals' liver disease drug, which is awaiting the regulator's traditional approval.
Sep 11, 2024 | www.reuters.com
Sophos Group (OTCMKTS:SPHHF) & Loomis AB (publ) (OTCMKTS:LOIMF) Financial Review
Loomis AB (publ) (OTCMKTS:LOIMF – Get Free Report) and Sophos Group (OTCMKTS:SPHHF – Get Free Report) are both business services companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, dividends, risk, institutional ownership and valuation. Analyst Recommendations This is a breakdown of current recommendations and price targets for Loomis AB (publ) and Sophos Group, as provided by MarketBeat.com. Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Loomis AB (publ) 0 0 0 0 N/A Sophos Group 0 0 0 0 N/A Volatility & Risk Loomis AB (publ) has a beta of 1.25, meaning that its stock price is 25% more volatile than the S&P 500. Comparatively, Sophos Group has a beta of 0.53, meaning that its stock price is 47% less volatile than the S&P 500. Valuation and Earnings This table compares Loomis AB (publ) and Sophos Group’s top-line revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Loomis AB (publ) $2.71 billion 0.64 $140.94 million $1.93 12.56 Sophos Group $710.60 million 4.61 $26.90 million $0.14 50.00 Loomis AB (publ) has higher revenue and earnings than Sophos Group. Loomis AB (publ) is trading at a lower price-to-earnings ratio than Sophos Group, indicating that it is currently the more affordable of the two stocks. Profitability This table compares Loomis AB (publ) and Sophos Group’s net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Loomis AB (publ) 4.98% 10.99% 3.92% Sophos Group N/A N/A N/A Summary Loomis AB (publ) beats Sophos Group on 7 of the 9 factors compared between the two stocks. About Loomis AB (publ) (Get Free Report) Loomis AB (publ) provides solutions for the distribution, payments, handling, storage, and recycling of cash and other valuables. The company offers a range of solutions for cash in transit, cash management services, foreign exchange services, automated teller machines, automated solutions, and international valuables logistics, as well as operates Loomis Pay, a payment service that enables processing of various types of payment methods, such as card, cash, and digital alternatives. It serves financial institutions, banks, retailers, commercial enterprises, and other customers, as well as public sector in Sweden, the United States, France, Switzerland, Spain, the United Kingdom, and internationally. Loomis AB (publ) was founded in 1852 and is headquartered in Stockholm, Sweden. About Sophos Group (Get Free Report) Sophos Group plc, through its subsidiaries, provides cloud-enabled end-user and network security solutions. The company offers XG Firewall, a next-generation firewall protection for network, users, and applications from new control center; SG UTM, a user interface to protect network and users; Secure Wi-Fi, a wireless access point; Secure Web Gateway for Web security; Secure Email Gateway solutions; and Phish Threat, an email phishing test simulation and training product. It also provides Endpoint Protection, a security solution for users and data; Intercept X, an endpoint security solution; Sophos Mobile, an enterprise mobility management solution; SafeGuard Encryption solution; Server Protection solution; Sophos Home, a protection solution for home computers; and Sophos Central, a synchronized security management solution. In addition, the company offers OEM solutions; professional services; SophosLabs, a threat research and intelligence center; and Public Cloud, a cloud computing solution to provide and deploy IT infrastructure, such as networks, compute capacity, storage, and databases. It serves education, healthcare, retail, finance, and banking industries, as well as governments and public sectors in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and Japan. Sophos Group plc was founded in 1985 and is headquartered in Abingdon, the United Kingdom.
May 20, 2024 | www.defenseworld.net

ICP's Email Address Formats

ICP uses at least 1 format(s):

ICP Email Formats	Example	Percentage
First@icpatlanta.com	John@icpatlanta.com	50%
First@icpatlanta.com	John@icpatlanta.com	50%

Frequently Asked Questions

Where is ICP's headquarters located?

ICP's main headquarters is located at 6040 Boat Rock Boulevard Southwest Atlanta, Georgia 30336 United States. The company has employees across 3 continents, including North AmericaAfricaAsia.

What is ICP's phone number?

You can contact ICP's main corporate office by phone at

+1-404-355-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is ICP's stock symbol?

ICP is a publicly traded company; the company's stock symbol is ICPT.

What is ICP's official website and social media links?

ICP's official website is icpatlanta.com and has social profiles on LinkedIn.

How much revenue does ICP generate?

As of February 2026, ICP's annual revenue is estimated to be $2.8M.

What is ICP's SIC code NAICS code?

ICP's SIC code is 7822 - Motion Picture and Video Tape Distribution NAICS code is 56192 - Convention and Trade Show Organizers.

How many employees does ICP have currently?

As of February 2026, ICP has approximately 17 employees across 3 continents, including North AmericaAfricaAsia. Key team members include Vp Warehouse Ops: T. L.President/Ceo: J. R.Owner: T. M.. Explore ICP's employee directory with LeadIQ.

What industry does ICP belong to?

ICP operates in the Events Services industry.

What technology does ICP use?

ICP's tech stack includes RSSCookie NoticeReactSlickWP Enginea3 Lazy LoadFacebookGoogle Plus.

What is ICP's email format?

ICP's email format typically follows the pattern of First@icpatlanta.com. Find more ICP email formats with LeadIQ.

When was ICP founded?

ICP was founded in 1979.

ICP

Q: What is ICP's official website and social media links?

ICP's official website is icpatlanta.com. ICP has social profiles on LinkedIn.

Q: How many employees does ICP have currently?

ICP has approximately 17 employees.

Q: What technology does ICP use?

ICP's tech stack includes Divi, Yoast SEO, Polyfill, Google Analytics, WP Engine.

Events ServicesGeorgia, United States11-50 Employees

Audio - Lighting - Staging - Set Design

Corporate Meeting
Concerts
Special events
Trade Shows 
Equipment Rentals

Company Overview

Headquarters: 6040 Boat Rock Boulevard Southwest Atlanta, Georgia 30336 United States
Phone number: +1-404-355-****
Website: icpatlanta.com
SIC Code: 7822 - Motion Picture and Video Tape Distribution
Stock Symbol: ICPT
NAICS Code: 56192 - Convention and Trade Show Organizers
Founded: 1979
Employees: 11-50

Media & News

Funding & Financials

$1M$10M
ICP's revenue is estimated to be in the range of $1M$10M

Funding & Financials

$1M$10M
ICP's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to ICP

IronCAD

SOLIDWORKS

ICP Tech Stack

Media & News

Intercept Pharma withdraws liver disease drug from US market

US FDA says Intercept's drug can cause liver injury in patients without scarring

US FDA declines full approval for Intercept's liver disease drug

Intercept Receives Complete Response Letter from FDA Addressing OCALIVA supplemental New Drug Application (sNDA)

FDA advisers vote against confirmatory data for Intercept's liver disease drug

FDA staff raises efficacy concerns over Intercept's liver disease drug

Sophos Group (OTCMKTS:SPHHF) & Loomis AB (publ) (OTCMKTS:LOIMF) Financial Review

ICP's Email Address Formats

Frequently Asked Questions

Where is ICP's headquarters located?

What is ICP's phone number?

What is ICP's stock symbol?

What is ICP's official website and social media links?

How much revenue does ICP generate?

What is ICP's SIC code NAICS code?

How many employees does ICP have currently?

What industry does ICP belong to?

What technology does ICP use?

What is ICP's email format?

When was ICP founded?

ICP

Company Overview

Media & News

Intercept Pharma withdraws liver disease drug from US market

US FDA says Intercept's drug can cause liver injury in patients without scarring

US FDA declines full approval for Intercept's liver disease drug

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?